










Supplementary Information for 
 




Hao Wang, Joshua A. Kulas, Chao Wang, David M. Holtzman, Heather A. Ferris, Scott B. Hansen 
 
Scott B. Hansen and Heather A. Ferris 
Email: shansen@scripps.edu, hf4f@virginia.edu  
 
 
This PDF file includes: 
 
Supplementary text 
Figures S1 to S7 
Extended Methods 







Limitations of the Study. CTxB is a pentadentate toxin that can cause artificial clustering (1). 
Density-based spatial clustering of applications with noise (DBSCAN), a commonly used 
clustering analysis algorithm allows for an accurate comparison of relative size between apoE-
treated and non-treated samples (Figure 1d), but does not necessarily correct artifacts in 
determining absolute size of the domain (Figure S5a) (2) (see also (3) for clustering artifacts that 
can affect determining absolute size). The changes in size are described as ‘apparent’ for this 
reason. Hence, the effects of a treatment are limited to an observed change in size due to a 
specific treatment or condition. None of the conclusions from pair correlations (Figures 2-3) are 
affected by clustering. In fact, artificial clustering may help pair correlations by tightening the 
boundary of GM1 domains and allowing a better determination of a protein that is in or out of the 
domain.  
Our data largely support the reliability of DRMs as a first approximation of cluster affinity (4, 5). 
Both dSTORM and DRMs found β, and γ-secretases firmly anchored in GM1 domains and α-
secretase unassociated. Some have argued DRMs are not always identical to GM1 domains (4, 
6), and we did see some differences. Compared to DRMs, our data show APP associates more 
readily with GM1 domains. We suspect the addition of detergents in the preparation of DRMs 
causes some APP to leave GM1 clusters although we cannot rule out dSTORM introducing 
clustering artifacts that increase APP association with GM1 domains in dSTORM.  
We used blood serum as a source of cholesterol for loading neurons. Serum has large lipoproteins 
like LDL and VLDL that are not present in the CNS.  In the CNS, apoE is only present in HDL like 
lipoproteins whose main effect is more in line with reverse cholesterol transport as seen when we 








Fig. S1. Amyloid proteins and substrate presentation. (a) The atomic structures of amyloid 
proteins and their predicted sub-membrane localizations based on palmitate mediated 
localization. Amyloid precursor protein (APP) and β- and γ-secretases are palmitoylated on their 
N-terminus. The palmitoylation is known to cause partitioning into detergent resistant membrane 
and GM1 clusters (green shading). α-secretase is not palmitoylated and is expected to reside in 
the disordered regions (grey shading). (b) The known APP cleavage sites for APP-processing 
proteins. In general, the α-secretase or β-secretase cleaves the APP extracellular domain 
generating the soluble N-terminal fragments (e.g. sAPPα or sAPPβ) and membrane-associated 
C-terminal fragments (CTF). CTFβ is further cleaved by the γ-secretase within the 
transmembrane domain releasing p3 peptide or β-amyloid (Aβ) peptide (respectively). (c) 
Substrate presentation is a biological process that activates a protein. The protein is sequestered 






Fig. S2. Super resolution imaging of enzymes and substrate localization with apoE and 
MβCD. (a) Confocal imaging on mouse brain showing GM1 lipids in plasma membrane of 
neurons. Neurons are labelled with neurofilament medium chains (NFM) antibody (red) and GM1 
lipids are labelled with fluorophore-conjugated cholera-toxin B subunit (CTxB, green). 
Representative images showing NFM filled the cell bodies of hippocampal neurons while GM1 
lipids are in the plasma membrane. (b) dSTORM imaging shows the effect of apoE on membrane 
protein’s cluster association (APP in magenta, GM1 in green) in N2a cells under low and high 
cholesterol conditions. Scale bar is 2 µm. (c-d) ApoE mediates a shift in distribution from small 
clusters (<150 nm) to larger clusters (>500 nm) under high cholesterol condition and opposite 
effect in low cholesterol condition; one-way ANOVA. (e) Cluster release assay showing treatment 
of N2a cells with apoE causes a palmitoyl reporter enzyme to exit the cluster and produce 





*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. (f) Exposure of neuroblastoma 2a (N2a) cells to 
either apoE3 or apoE4 removes cholesterol from cellular membrane measured by a fluorescent 
based cholesterol assay. (g-n) Under low cholesterol conditions (-Chol), APP’s cluster association 
decreases markedly after apoE treatment. Under high cholesterol conditions (+Chol), apoE-
mediated APP co-localization with GM1 clusters increases (i.e., apoE induces APP to translocate 
into lipid clusters). α-, β- and γ-secretase localization do not respond to apoE-mediated cluster 
modulation. (o) Apparent cluster size of neuroblastoma 2a (N2a) cells before and after treatment 
with methyl-β-cyclodextrin (MβCD). (p) Cholesterol extraction by MβCD mediates a shift in cluster 
size distribution from large clusters (>500 nm) to smaller clusters (<150 nm). (q) Lipid cluster 
disruption by MβCD moves APP from lipid clusters into disordered region. (r-s) β- and γ-






Fig. S3. ApoE’s effect on secretases in cortical neurons (a) Apparent cluster size of primary 
cortical neurons before and after treatment with apoE in mixed culture with astrocytes. (b) Cluster 
size distribution analysis showing apoE mediates a shift in distribution from small clusters (<150 
nm) to larger clusters (>500 nm) in cortical neurons when culturing with astrocytes. (c-e) α-, β- 
and γ-secretase lipid cluster localization in cortical neurons do not respond to apoE-mediated 
cluster modulation when culturing with astrocytes. Data are expressed as mean ± s.e.m., n=3-10, 







Fig. S4. Induction of astrocyte SREBP2 gene ablation disrupts the cholesterol synthesis 
enzyme FDFT1 and abolishes APP and GM1 pair correlation. (a) Astrocyte-neuron co-cultures 
were grown from SREBP2flox/flox Aldh1L1-CreERT2 embryos. Astrocyte SREBP2 knockout was 
induced by application of 4-hydroxytamoxifen (TMX) to cultures. Following knockout, cells were 
immunostained for the cholesterol synthesis enzyme FDFT1 and the astrocyte marker GFAP and 
imaged. (b) Mixed primary cultures of neurons and astrocytes derived from SREBP2flox/flox x 
Aldh1L1-Cre and Cre negative littermates were treated with 4-hydroxytomoxifen (TMX) to delete 
SREBP2. APP lipid cluster localization in cortical neurons is lost when SREBP2 is knocked out of 
astrocytes. TMX does not change APP localization in Cre negative cells. Data are expressed as 






Fig. S5. Analysis of cluster size. Comparison of the size of CTxB labeled GM1 domains from 
primary neurons and N2a cells with antibody labeled γ-secretase. The potential added diameter 
from antibody or CTxB labeling is indicated by white stripes. Fixed γ-secretase within the GM1 
lipids form clusters approximately the same size as CTxB labeled GM1 clusters, suggesting CTxB 







Fig. S6. Loss of astrocyte SREBP2 in the 3xTg AD models does not impact total transgene 
protein levels or ApoE in the hippocampus. 3xTg-AD (AD) mice express transgenes for mutant 
human amyloid precursor protein (APP) and tau. The AD mice were crossed to 
SREBP2flox/floxGFAP-Cre+/- mice and littermate females with intact SREBP2 (AD x SB2flox) or 
deleted SREBP2 (AD x SB2-/-) were compared. Control mice do not express the human 
transgenes. (a) Animals were aged to 40 weeks and hippocampus tissue was dissected and 
homogenized for western blot. Data are expressed as mean ± s.e.m., n=3-4 animals per 
genotype. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, one-way ANOVA with Tukey’s post hoc 
analysis. (b) GFAP and ApoE were measured in 40-week-old female ADxSB2flox and ADxSB2-







Fig. S7. Primary astrocyte cultures release apoE into cell culture media. C57BL6/J control 
and APOE-/- mouse astrocytes were maintained in neurobasal media supplemented with B27 for 
72 hours. Media was collected and concentrated to test for the presence of apoE protein by 
western blot. Total protein imaged on stain-free gel (left panel) for unconcentrated and 
concentrated astrocyte conditioned media (ACM). Right panel, western blot demonstrates 
presence of ApoE in C57Bl6/J-derived ACM, but absence in media alone (neurobasal + B27) or 







Housing, animal care and experimental procedures were consistent with the Guide for the Care 
and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee 
of the Scripps Research Institute and the University of Virginia. 3xTg-AD mice and B6129SF2/J 
controls were purchased from Jackson labs. The 3xTg-AD mice were maintained homozygous 
for all transgenes. SREBP2flox/flox mice (a generous gift of Dr. Jay Horton at UT Southwestern, 
now available through Jackson labs) were crossed to the hGFAP-Cre as previously described (7). 
These mice were in turn bred to the 3xTg-AD line and crossed back to homozygosity for both the 
3xTg-AD transgenes and the SREBP2-flox. 3xTg-AD x SREBP2flox/flox (AD x SB2flox) and 3xTg-
AD x SREBP2flox/flox x GFAP-Cre (AD x SB2-/-) are littermates. Only female mice were used for the 
AD crosses as the male 3xTg-AD mice have a much milder phenotype. 
Aldh1l1-CreERT2 mice were purchased from Jackson labs. These mice were crossed to the 
SREBP2flox/flox mice and the floxed allele was kept homozygous. Both male and female embryos 
were used from this mouse line. ApoE knockout mice utilized in astrocyte culture experiments 
were purchased from Jackson Labs. 
To generate APPPS1-21/apoE3 or apoE4 mice (APP/PS1/E3F or APP/PS1/E4F, respectively), 
APPPS1-21 (APPPS1) transgenic mice were crossed with human APOE3 or APOE4 KI (E3F or 
E4F, respectively) mice (8) for several generations. 
Cell culture 
Neuroblastoma 2a (N2a) cells and human embryonic kidney 293T (HEK293T) cells were grown 
in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. The cells were changed to a serum-free media 24 hours prior to 
experimentation unless otherwise noted. 
Neurons were isolated from the cortices of embryonic day 18-21 CD1 mice. Cells were 
dissociated by papain digestion and plated on poly-D-lysine-coated (0.01 mg/mL) 8-well Lab-Tek 
II chambered cover glass (Thermo Fisher Scientific, #Z734853). Specifically, dissociated cells 
were plated in Minimum Essential Medium (MEM) supplemented with 5% FBS and 0.6% glucose 
and grown in Neurobasal medium (Thermo Fisher Scientific) supplemented with 20% B27 
(Invitrogen), 1% Glutamax and 1% penicillin/streptomycin at 37 °C in 5% CO2. Cells were cultured 
in vitro for two days prior to experiment. Astrocytes were cultured in DMEM containing 10% FBS 
and 1% penicillin/streptomycin as described previously (9).  
Inducible Astrocyte SREBP2 Knockout Cultures 
Astrocyte SREBP2 knockout cells with WT neuron cocultures were grown by breeding ALDH1L1-
CreERT2xSREBP2flox/flox mice with SREBP2flox/flox mice. Embryonic day 17 brain cortices were 
harvested from embryos and cultured individually, while tails from each individual embryo were 
collected for determination of Cre genotype. Meninges-free embryo cortices were digested in 
papain supplemented with DNAse for 30 minutes then digestion was terminated by 4:1 addition 
of sterile HBSS + 20% fetal bovine serum.  Following enzymatic dissociation, cells were 
centrifuged at 300 x g for 3 minutes. The resulting cell pellet was gently resuspended in plating 
media (MEM + 5% FBS + 0.6% glucose) using a 1mL pipette. Cells were plated on 0.01 mg/mL 
poly-d-lysine overnight coated Nunc™ Lab-Tek™ II 8-chambered cover glass or glass coverslips 
in plating media and placed in a 37-degree 5% CO2 cell culture incubator. After two hours, plating 
media was gently removed from the cells and replaced with neurobasal media supplemented with 
20% B27 and 1% Glutamax. After 4 days in culture, astrocyte SREBP2 ablation was induced by 





hours 4-OH tamoxifen was removed and media was replaced with fresh neurobasal media 
containing 20% B27 and 1% Glutamax. Cells were then maintained in culture for 4 days and fixed 
for imaging as described below. 
3xTg Astrocyte SREBP2 Knockout Cultures 
Mixed cultures of 3xTg neurons with WT or SREBP2 knockout astrocytes were generated from 
embryos by breeding 3xTg SREBP2flox/flox mice with 3xTg SREBP2flox/flox hGFAP-Cre mice. On 
embryonic day 17, the embryos were harvested and the cortices and tail of each embryo were 
collected for cell culture and PCR genotyping respectively. The mixed cultures were grown from 
individual embryonic cortices as performed in the inducible system described above, however 
cells were seeded at a high density (approximately 200,000 cells/well) to allow for a high density 
of neurons and astrocytes. After 3 days in culture, the cell culture media was exchanged for fresh 
supplemented neurobasal media. The culture media and cell lysate were then collected for ELISA 
and western blot experiments. Conditioned media was concentrated for western blot by addition 
of 250 μL trichloroacetic acid (1.42g/mL H2O) to 1 mL of conditioned media. Protein was 
precipitated for 20 minutes on ice and pelleted by centrifugation at 20,000 RCF at 4 degrees C. 
The pellet was then washed twice with ice cold acetone and resuspended in Laemmli buffer under 
reducing conditions.  
Astrocyte conditioned media treatment of hGFAP-Cre neuron cultures 
Primary astrocyte cultures from C57BL6/J and APOE-/- mice were grown from 2-day-old mouse 
pups using established methods. Brain cortices were harvested and meninges removed. Tissue 
was then digested in trypsin with DNAse for 30 minutes. Digestion was terminated using 10% 
FBS in DMEM/F12 and cells were centrifuged at 500 RCF for 10 minutes. The cell pellet was then 
suspended in astrocyte growth media (DMEM/F12 + 10% FBS + Penicillin streptomycin). The 
cells were plated into cell culture flasks (4 pup cortices/flask) with media refreshed after 24 hours. 
When cultures became confluent with astrocytes after 1 week, the culture flasks were shaken on 
an orbital shaker at 500 RPM for 6 hours to remove microglia. The astrocytes were then washed 
2 times with sterile PBS. 15 mL of Neurobasal media supplemented with B27 and 
Penicillin/streptomycin was then added to the astrocyte cultures for conditioning. This media was 
conditioned with the astrocytes for 72 hours and then collected for subsequent experiments. For 
treatment of neurons, the astrocyte conditioned media (ACM) was collected from culture flasks 
and centrifuged for 10 minutes at 3000 RCF to remove cell debris. 0.5 mL of ACM was added to 
1 mL of neuronal culture media and applied to primary embryonic hGFAP-Cre x SREBP2flox/flox 
neuron cultures grown on glass coverslips in 12 well plates. The neurons were in culture for 7 
days at the time of ACM treatment. The ACM from control or APOE-/- astrocytes was applied to 
neurons for 24 hours. After treatment, neurons were washed with PBS and fixed for dSTORM 
analysis. ACM used in western blot experiments was concentrated using Millipore 10kD 
centrifugal filters (MRCPRT010) by centrifugation at 14,000 RCF for 20 minutes. 
dSTORM Super-resolution imaging 
Fixed cell preparation 
N2a cells were grown to 60% confluence and then allowed to differentiate overnight in serum free 
media. Primary cortical cells were grown for two days in vitro. Cells were incubated with 4 μg/mL 
purified apoE protein for one hour in media with or without FBS supplementation. Cells were 
rinsed with PBS and then fixed with 3% paraformaldehyde and 0.1% glutaraldehyde for 15 min to 
fix both proteins and lipids. Fixative chemicals were reduced by incubating with 0.1% NaBH4 for 
7 min with shaking followed by three times 10 min washes with PBS. Cells were permeabilized 
with 0.2% Triton X-100 for 15 min and then blocked with a standard blocking buffer (10% bovine 





were incubated with primary antibody (APP: Abcam, #ab15272; γ-secretase: Sigma, #MAB5232; 
β-secretase: Abcam, #ab10716; α-secretase: Santa Cruz, #sc-48400) for 60 min in 5% BSA / 
0.05% Triton / PBS at room temperature followed by 5 washes with 1% BSA / 0.05% Triton / PBS 
for 15 min each. Secondary antibody was added in the same buffer as primary for 30 min at room 
temperature followed by 5 washes as stated above. Cells were then washed with PBS for 5 min. 
Cell labelling and washing steps were performed while shaking. Labeled cells were then post-
fixed with fixing solution, as above, for 10 min without shaking followed by three 5 min washes 
with PBS and two 3 min washes with deionized distilled water.  
The specificity of the APP antibody (ab15272) used for dSTORM staining in this study was 
validated by western blot with an expected MW of 87 kDa (see manufacture product page). A 
second APP antibody (ab32136), validated in KO animals, was used for the western blots. The y-
secretase antibody (MAB5232) binds to proteolyzed PS1—mutation that blocks proteolysis and 
shifted all the major bands to full length demonstrating this antibody’s specificity (10).  Western 
blots of rat brain with 𝛼-secretase antibody (sc-48400) produces a single band of the appropriate 
MW (see product website). The BACE1 antibody from Abcam used in this study (product 
#ab10716) has potential cross contamination with a 42 kDa protein (see product website). We did 
not verify in our N2a cells if this cross contamination is present. However, we did not see a shift 
in BACE1 antibody localization with treatment, suggesting if there is cross reactivity, both BACE1 
and the putative protein behave the same. 
Brain slice preparation 
Mouse brain slicing and staining were performed as previously described (11) with minor 
modifications. Mouse brains were fixed in 4% paraformaldehyde, incubated in a 20% 
sucrose/PBS solution at 4 °C for 3 days, and embedded in Tissue-Tek OCT compound (Sakura). 
Sagittal sections (50 μm) were collected and placed into 24-well plate wells containing PBS. 
Fixative chemicals were reduced by incubating with 0.1% NaBH4 for 30 min while gently shaking 
at room temperature followed by three times 10 min washes with PBS. Samples were 
permeabilized with 0.2% Triton X-100 for 2 hours and then blocked with a standard blocking buffer 
(10% bovine serum albumin (BSA) / 0.05% Triton in PBS) for 6 hours at room temperature. For 
labelling, samples were incubated with primary antibody for 3 hours in 5% BSA / 0.05% Triton / 
PBS at room temperature then 3 days at 4 °C followed by 5 washes with 1% BSA / 0.05% Triton 
/ PBS for 1 hour each. Secondary antibody was added in the same buffer as primary for 3 days 
at 4 °C followed by 5 washes as stated above. Sample labelling and washing steps were 
performed while shaking. Labeled brain tissues were then post-fixed with fixing solution, as above, 
for 1 hour without shaking followed by three 30 min washes with PBS and two 30 min washes 
with deionized distilled water. Brain slices were mounted onto the 35 mm glass bottom chamber 
(ibidi, #81158) and 2% agarose were pipetted onto the slice to form a permeable agarose pad 
and prevent sample movement during imaging.  
dSTORM imaging  
Images were recorded with a Zeiss ELYRA PS.1 microscope using TIRF mode equipped with a 
pil-immersion 63x objective. Andor iXon 897 EMCCD camera was used along with the Zen 10D 
software for image acquisition and processing. The TIRF mode in the dSTORM imaging provided 
low background high-resolution images of the membrane. A total of 10,000 frames with an 
exposure time of 18 ms were collected for each acquisition. Excitation of the Alexa Fluor 647 dye 
was achieved using 642 nm lasers and Cy3B was achieved using 561 nm lasers. Cells and brain 
tissues were imaged in a photo-switching buffer comprised of 1% β-mercaptoethanol (Sigma, 
#63689), oxygen scavengers (glucose oxidase (Sigma, #G2133) and catalase (Sigma, #C40)) in 
50mM Tris (Affymetrix, #22638100) + 10mM NaCl (Sigma, #S7653) + 10% glucose (Sigma, 





Images were constructed using the default modules in the Zen software. Each detected event 
was fitted to a 2D Gaussian distribution to determine the center of each point spread function plus 
the localization precision. The Zen software also has many rendering options including removing 
localization errors and outliers based on brightness and size of fluorescent signals. Pair 
correlation and cluster analysis was performed using the Statistical Analysis package in the 
Vutara SRX software. Pair Correlation analysis is a statistical method used to determine the 
strength of correlation between two objects by counting the number of points of probe 2 within a 
certain donut-radius of each point of probe 1. This allows for localization to be determined without 
overlapping pixels as done in traditional diffraction-limited microscopy. Cluster size estimation 
was calculated through cluster analysis by measuring the area of the clusters comprising of more 
than 10 particles with a maximum particle distance of 0.1 µm. Cluster size of brain slices was 
calculated from >3 fields of view from one animal. 
Fluorescence activated cell sorting (FACS) of live cells 
Live cell staining for FACS was performed as previously described (12). Immediately after 
dissection and dissociation, cortical cells from embryonic mice were labelled with Brilliant Violet 
421TM anti-mouse CD90.2 (Thy1.2) antibody (BioLegend, #140327). Cells were incubated with 
antibody at 4 °C for 20 minutes followed by washing with wash buffer (Ca2+/Mg2+ free PBS, 1mM 
EDTA, 25mM HEPES, 5% FBS, 10 units/mL DNase II). Cells were filtered through a 40-µm nylon 
filter (Corning, #431750) and sorted in a BD Biosciences FACSAria3 sorter. Thy1.2+ neurons 
were collected and cultured as described above. 
Live cell cluster affinity assay 
Modulation of cluster integrity was detected by a biochemical assay based on the activity of a 
palmitate mediated cluster localized enzyme phospholipase D (PLD), as described previously18. 
Briefly, N2a cells were seeded into 96-well flat culture plates with transparent-bottom (CorningTM 
CostarTM, #3585) to reach confluency (~ 5 x 104 per well). Then the confluent cells were 
differentiated with serum-free DMEM for a day and washed with 200 μL of PBS. The cluster 
integrity assay reactions were promptly begun by adding 100 μL of working solution with or without 
apoE, (BioVision, #4696).  The working solution contained 50 μM Amplex red, 1 U/mL horseradish 
peroxidase, 0.1 U/mL choline oxidase, and 30 μM dioctanoyl phosphatidylcholine (C8-PC). ApoE 
was directly dissolved into the working buffer from freshly made stocks before assay reagents 
were added. The PLD activity and the background (lacking cells) was determined in triplicate for 
each sample by measuring fluorescence activity with a fluorescence microplate reader (Tecan 
Infinite 200 PRO, reading from bottom) for 2 hours at 37°C with excitation wavelength of 530 nm 
and an emission wavelength of 585 nm. Subsequently, PLD activity was normalized by 
subtracting the background and to the control activity. Data were then graphed (Mean ± s.e.m.) 
and statistically analyzed (one-way ANOVA) with GraphPad Prism software (v6.0f). 
Live cell cholesterol assay 
To measure the relative changes in plasma membrane cholesterol after apoE treatment, we 
developed an Amplex Red-based cholesterol assay in live cells, modified from the cluster integrity 
assay described above. Briefly, N2a cells or astrocytes were seeded into 96-well flat culture plates 
with transparent-bottom to reach confluency (~ 5 x 104 per well). Then the confluent cells were 
differentiated with serum-free DMEM for a day. Cells were incubated with fresh DMEM for 1 hour 
followed by 1 hour of incubation in 100 μL of DMEM medium with or without treatment. After 
washing with 200 μL of PBS, cholesterol assay reactions were promptly begun by adding 100 μL 
of working solution containing 50 μM Amplex red, 1 U/mL horseradish peroxidase, 2 U/mL 
cholesterol oxidase and 2 U/mL cholesterol esterase in PBS. Relative cholesterol concentration 
and the background (lacking cells) was determined in triplicate for each sample by measuring 





bottom) for 2 hours at 37°C with excitation wavelength of 530 nm and an emission wavelength of 
585 nm. Subsequently, cholesterol level was normalized to the control activity after subtracting 
the background. End point cholesterol signals were then graphed (Mean ± s.e.m.) and statistically 
analyzed (one-way ANOVA) with GraphPad Prism software (v6.0f). 
ELISA 
To measure the relative changes in β- and α- cleavage products of APP, N2a cells were incubated 
with apoE with and without FBS supplementation for 1 hour, then washed with PBS once and 
incubated with PBS for 1 hour. Supernatants were harvested and analyzed with Aβ40 and sAPPα 
ELISAs.  
Relative quantitation of secreted Aβ40 was performed with commercial human Aβ40 ELISA kit 
(Invitrogen, #KHB3481) following the manufacturer’s instructions. For sAPPα ELISA, 5 μg/mL 
rabbit anti-APP antibody (abcam, #ab15272) was coated on immunoassay plates (CorningTM 
CostarTM Cell Culture 96 well plates, #3585) at 4 °C overnight. Then, the plates were washed with 
PBS three times. Next, 50 μL of supernatant was added and incubated at room temperature for 
1 hour. After this, 50 μL of 2 μg/mL mouse anti-human sAPPα IgG monoclonal antibody (IBL, 
#11088) was added as primary detection antibody. After incubation for 3 hours at room 
temperature, the plates were washed with PBST buffer (PBS with 0.05% Tween-20) and then 100 
μL of 100 ng/mL HRP-linked rabbit anti-mouse IgG secondary antibody (Invitrogen, #31450) was 
added and incubated for 1 hour. An HRP substrate, chromogen (Invitrogen, #KHB3481) was 
added and incubated at room temperature in the dark for 30 minutes. The substrate development 
was terminated by adding 100 μL of stop solution from ELISA kit (Invitrogen, #KHB3481). Relative 
sAPPα concentration was determined by measuring absorbance at 450 nm using a microplate 
reader (Tecan Infinite 200 PRO). 
Amyloid and p-Tau ELISA from Mouse Hippocampus  
Human amyloid beta 1-40 (R&D Systems DAB140B) and 1-42 (R&D Systems DAB142) was 
quantified in mouse hippocampus tissue using commercially available ELISA kits per 
manufacturer’s instructions. 60-week-old female mouse whole hippocampus tissue was 
homogenized in RIPA buffer (Bioworld, 42020024-2) with protease inhibitors (Thermo Fisher 
Scientific, 78430) using a Bullet Blender® (Next-Advance) with zirconium oxide beads. The 
homogenate was centrifuged at 15,000 x g for 10 minutes, and the supernatant was collected to 
yield RIPA soluble amyloid. The remaining tissue pellet was then resuspended in 5 M guanidine-
HCl diluted in 50 mM Tris, pH 8.0 with protease inhibitor and mechanically agitated at room 
temperature for 4 hours to extract the RIPA insoluble amyloid. Guanidine samples were diluted 
1:10 in sterile PBS and centrifuged at 16,000 x G for 20 minutes. Supernatant was then collected 
to yield insoluble amyloid. Both soluble and insoluble amyloid supernatants were then assessed 
for total protein content using the Pierce 660 protein assay (Thermo Fisher Scientific, 22660). All 
samples were then diluted to equal concentrations of total protein. Prior to ELISA, samples were 
diluted 1:10 to prevent oversaturation of ELISA signal. Human phospho-tau [pT181] was 
measured using a commercially available ELISA per manufacturer’s instructions (Thermo Fisher 
Scientific, KHO0631). Guanidine extracted supernatants of hippocampus homogenates 
described above were utilized for the pTau ELISA. 
Confocal imaging on brain slices and primary cells 
Mouse brains were fixed in 4% paraformaldehyde, incubated in a 20% sucrose/PBS solution at 4 
°C for 3 days, and embedded in Tissue-Tek OCT compound (Sakura). Sagittal sections (50 μm) 
were collected on Superfrost/Plus slides and immunostained with mouse NF-M antibody (Santa 
Cruz, #sc-398532), Alexa Fluor-647-conjugated CTxB (Invitrogen, #C34778) and Cy3B-





antibody from Cell Signaling (#8243) with Alexa Fluor 594 anti-rabbit secondary (Thermo Fisher 
Scientific, #A21207). Primary cortical cells were fixed and labelled with Alexa Fluor-488-
conjugated mouse GFAP antibody (Biolegend, #644704), or rabbit GFAP antibody (Millipore, 
#MAB360) with Alexa Fluor 594 anti-rabbit secondary (Thermo Fisher Scientific, #A21207). 
SREBP2 knockout was confirmed by measuring the downstream enzyme FDFT1 (Abcam, 
#ab195046, Alexa Fluor 488 secondary Thermo Fisher Scientific #A32766) pTau was imaged in 
brain sections using the mouse monoclonal AT180 antibody from Thermo Fisher Scientific 
(#MN1040). Samples were imaged on Leica TCS SP8 confocal microscope using a 25x water 
emersion objective. ImageJ was used to analyze images.  
Tissue Western Blots 
40-week-old mouse hippocampus tissue was homogenized in RIPA buffer with protease inhibitors 
using a Bullet Blender®. The homogenate was centrifuged at 15,000 x g for 10 minutes, and the 
supernatant was collected. Total protein content was measure using the Pierce 660 absorbance 
assay. Sample protein content was diluted to equal concentrations, and Laemmli buffer (Biorad, 
1610737) was added to each sample for SDS-Page. SDS-Page was performed to resolve protein 
by molecular weight using 10 micrograms of hippocampal lysate from each sample in 4-20% 
acrylamide pre-cast gels (Biorad, 4568094). Resolved protein was transferred to PVDF 
membrane and blocked with 5% BSA solution in PBST. Primary antibodies against target proteins 
were applied overnight at 4 C. Membranes were then washed and fluorescent secondary 
antibodies were applied for 2 hours at room temperature. Following 5 washes with TBS with 0.1% 
tween, membranes were imaged using the Bio Rad chemidoc MP fluorescent imaging system. 
Primary antibodies used in this study include: APP (Y188), Abcam, #ab32136; tau, Fisher 
Scientific, #AHB0042; Cre, Biolegend, #908001; Actin, Biorad, #12004163; sAPPβ, BioLegend, 
#813401; ApoE, Abcam, #ab183597. 
Mass Spectrometry  
Lipidomics profiling was performed using Ultra Performance Liquid Chromatography-Tandem 
Mass Spectrometry (UPLC-MSMS).  
Lipid extracts were prepared from cell preparations using modified Bligh and Dyer method, spiked 
with appropriate internal standards, and analyzed on a platform comprising Agilent 1260 Infinity 
HPLC integrated to Agilent 6490A QQQ mass spectrometer controlled by Masshunter v 7.0 
(Agilent Technologies, Santa Clara, CA). Glycerophospholipids and sphingolipids were separated 
with normal-phase HPLC. An Agilent Zorbax Rx-Sil column ( 2.1 x 100 mm, 1.8 µm) maintained 
at 25°C was used under the following conditions: mobile phase A (chloroform: methanol: 
ammonium hydroxide, 89.9:10:0.1, v/v) and mobile phase B (chloroform: methanol: water: 
ammonium hydroxide, 55:39:5.9:0.1, v/v); 95% A for 2 min, decreased linearly to 30% A over 18 
min and further decreased to 25% A over 3 min, before returning to 95% over 2 min and held for 
6 min. Separation of sterols and glycerolipids was carried out on a reverse phase Agilent Zorbax 
Eclipse XDB-C18 column (4.6 x 100 mm, 3.5um) using an isocratic mobile phase,  chloroform, 
methanol, 0.1 M ammonium acetate (25:25:1) at a flow rate of 300 μL/min. 
Quantification of lipid species was accomplished using multiple reaction monitoring (MRM) 
transitions under both positive and negative ionization modes in conjunction with referencing of 
appropriate internal standards: PA 14:0/14:0, PC 14:0/14:0, PE 14:0/14:0, PG 15:0/15:0, PI 
17:0/20:4, PS 14:0/14:0, BMP 14:0/14:0, APG 14:0/14:0, LPC 17:0, LPE 14:0, LPI 13:0, Cer 
d18:1/17:0, SM d18:1/12:0, dhSM d18:0/12:0, GalCer d18:1/12:0, GluCer d18:1/12:0, LacCer 
d18:1/12:0, D7-cholesterol, CE 17:0, MG 17:0, 4ME 16:0 diether DG, D5-TG 16:0/18:0/16:0 
(Avanti Polar Lipids, Alabaster, AL). Lipid levels for each sample were calculated by summing up 
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